Literature DB >> 6636539

Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization.

M Bruns, J Cihak, G Müller, F Lehmann-Grube.   

Abstract

A structural glycoprotein of lymphocytic choriomeningitis virus was obtained in pure form by immunoaffinity chromatography using a monoclonal antibody with high neutralizing activity. It blocked neutralization of viral infectivity by antibody and in polyacrylamide gel electrophoresis it migrated with an apparent molecular weight of 44 X 10(3). We conclude that the isolated material is identical with the previously described gp44 (GP-1).

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6636539     DOI： 10.1016/0042-6822(83)90135-6

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  36 in total

1.  Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

Authors:  H Miletic; M Bruns; K Tsiakas; B Vogt; R Rezai; C Baum; K Kühlke; F L Cosset; W Ostertag; H Lother; D von Laer
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference.

Authors:  W R Beyer; H Miletic; W Ostertag; D von Laer
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Authors:  K Schwarz; R de Giuli; G Schmidtke; S Kostka; M van den Broek; K B Kim; C M Crews; R Kraft; M Groettrup
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

4.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.

Authors:  Winfried R Beyer; Dennis Pöpplau; Wolfgang Garten; Dorothee von Laer; Oliver Lenz
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus.

Authors:  Roland C Zahn; Ina Schelp; Olaf Utermöhlen; Dorothee von Laer
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

8.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Viral nucleoprotein can be demonstrated on the surface of lymphocytic choriomeningitis virus-infected cells.

Authors:  W Zeller; M Bruns; F Lehmann-Grube
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

10.  Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.

Authors:  Lars Hangartner; Beatrice M Senn; Birgit Ledermann; Ulrich Kalinke; Peter Seiler; Etienne Bucher; Raphaël M Zellweger; Katja Fink; Bernhard Odermatt; Kurt Bürki; Rolf M Zinkernagel; Hans Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.